Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Journal of Travel Medicine|May 9, 2022
Post malaria acute motor axonal neuropathySouheil Zayet, Timothée Klopfenstein, Isabelle Quadrio, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|February 11, 2015
Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteriaKina Höglund, Anthony Fourier, Armand Perret-Liaudet, et al.Journal of Neurology|June 3, 2025
Impact of the intronic RFC1 expansion size in CANVAS phenotype: an oculomotor studyMathieu Dupré, Ruben Hermann, Léo Vidoni, et al.Molecular Genetics & Genomic Medicine|August 23, 2019
Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptomsFrancis Ramond, Isabelle Quadrio, Laurence Le Vavasseur, et al.Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapyIngrid Dupiereux, Willy Zorzi, Isabelle Quadrio, et al.Chemical Communications (Cambridge, England)|June 7, 2022
Charge detection mass spectrometry on human-amplified fibrils from different synucleinopathiesAikaterini Tsirkou, Flora Kaczorowski, Mathieu Verdurand, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 16, 2024
Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsAntonio Farina, Macarena Villagrán-García, Marie Benaiteau, et al.Cerebral Circulation - Cognition and Behavior|November 28, 2025
Late-onset dementia with leukoencephalopathy and a <i>COL4A2</i> gene variant, causal link or fortuitous association: a case reportAntoine Garnier-Crussard, Alexandre Bani-Sadr, Isabelle Quadrio, et al.Journal of Neuroimmunology|June 1, 2024
Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathyAntoine Pegat, Jean-Baptiste Chanson, Pierre Lozeron, et al.Translational Psychiatry|September 1, 2025
[<sup>18</sup>F]FDG PET metabolic patterns of the rapid-acting antidepressant effects of NLX-101, a 5-HT<sub>1A</sub> receptor biased agonistSarah Chaib, Elise Levigoureux, Sandrine Bouvard, et al.Pageof 8